OPKO Health - 53 Year Dividend History | OPK

Historical dividend payout and yield for OPKO Health (OPK) since 1971. The current TTM dividend payout for OPKO Health (OPK) as of May 20, 2024 is $0.00. The current dividend yield for OPKO Health as of May 20, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.920B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio